0001348362-19-000007.txt : 20191119 0001348362-19-000007.hdr.sgml : 20191119 20191119131628 ACCESSION NUMBER: 0001348362-19-000007 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191119 DATE AS OF CHANGE: 20191119 EFFECTIVENESS DATE: 20191119 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Lexaria Bioscience Corp. CENTRAL INDEX KEY: 0001348362 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 202000871 STATE OF INCORPORATION: NV FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-353721 FILM NUMBER: 191230274 BUSINESS ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 BUSINESS PHONE: 250-765-6424 MAIL ADDRESS: STREET 1: 100 - 740 MCCURDY ROAD CITY: KELOWNA STATE: A1 ZIP: V1X 2P7 FORMER COMPANY: FORMER CONFORMED NAME: LEXARIA CORP. DATE OF NAME CHANGE: 20080229 FORMER COMPANY: FORMER CONFORMED NAME: Lexaria Corp. DATE OF NAME CHANGE: 20051229 D 1 primary_doc.xml X0708 D LIVE 0001348362 Lexaria Bioscience Corp. 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 250-765-6424 NEVADA LEXARIA CORP. Lexaria Corp. Corporation true CHRIS BUNKA 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director JOHN DOCHERTY 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer Director ALLAN SPISSINGER 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Executive Officer NICHOLAS BAXTER 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director TED MCKECHNIE 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director BRIAN QUIGLEY 100 - 740 MCCURDY ROAD KELOWNA A1 BRITISH COLUMBIA, CANADA V1X 2P7 Director Biotechnology $1 - $1,000,000 06b false 2019-11-13 true true true true true Each Unit is comprised of one common share and one common share purchase warrant. Each warrant is exercisable for one common share at an exercise price of $0.80 for 12 months and after such 12 months, at an exercise price of $1.20 for 12 months. false 0 2357594 492500 1865094 The additional $1,865,094.00 may be received upon the exercise of share purchase warrants sold inside and outside the U.S. false 5 0 0 0 In the ordinary course of business, the issuer may use some of the proceeds of the offering to pay salaries to certain of its executive officers and directors. false Lexaria Bioscience Corp. CHRIS BUNKA CHRIS BUNKA CHIEF EXECUTIVE OFFICER 2019-11-19